https://pubmed.ncbi.nlm.nih.gov/38114161
This study proposes a stage-based approach to treating coronary heart disease with anxiety and depression, targeting phlegm, blood stasis, and toxicity in chronic, developmental, and acute phases, respectively, to improve both organic damage and emotional disorders.